PLx Pharma Inc. (PLXP) financial statements (2022 and earlier)

Company profile

Business Address 9 FISHERS LANE
SPARTA, NJ 07871
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:69,39222,44914,00114,25024,40416,70032,200
Cash and cash equivalents69,39222,44914,00114,25024,40416,6755,235
Short-term investments      26,977
Other undisclosed cash, cash equivalents, and short-term investments     25(12)
Receivables634 191819  
Inventory, net of allowances, customer advances and progress billings2,458100(500)(1,003)246  
Inventory2,458100(500)(1,003)246  
Prepaid expense   409300359146
Deferred costs2,458143 175   
Deposits current assets    4  
Other undisclosed current assets(1,466)2937631,016716(25)12
Total current assets:73,47622,98614,28314,86525,69017,03432,358
Noncurrent Assets
Operating lease, right-of-use asset230327618
Property, plant and equipment8581,2261,4671,3941,030  
Intangible assets, net (including goodwill), including:2,0612,0612,0612,0612,061  
Goodwill2,0612,0612,0612,0612,061  
Intangible assets, net (excluding goodwill)    2,294  
Other undisclosed intangible assets, net (including goodwill)    (2,294)  
Deposits noncurrent assets1717746868  
Other noncurrent assets     5749
Total noncurrent assets:3,1663,6314,2193,5233,1595749
TOTAL ASSETS:76,64226,61718,50318,38828,84917,09132,408
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:10,6008639296538522,1221,606
Accrued liabilities     1,04056
Employee-related liabilities     579663
Interest and dividends payable 5973560   
Other undisclosed accounts payable and accrued liabilities10,600265894593852503887
Debt 6223,6582,910   
Other liabilities1162753056160  
Other undisclosed current liabilities1,1631,7821,2021,109904  
Total current liabilities:11,8793,5426,0934,7331,8162,1221,606
Noncurrent Liabilities
Long-term debt and lease obligation  6224,2806,942  
Long-term debt, excluding current maturities  6224,2806,942  
Liabilities, other than long-term debt12,9549,8258,6572,62215,385  
Other liabilities13613440984142  
Derivative instruments and hedges, liabilities12,8189,6918,2482,53715,243  
Other undisclosed noncurrent liabilities1292,7961,56030990  
Total noncurrent liabilities:13,08312,62110,8407,21122,416  
Total liabilities:24,96216,16416,93311,94424,2322,1221,606
Stockholders' equity
Stockholders' equity attributable to parent35,666(10,932)(12,092)6,4444,61614,96930,802
Common stock28149991110
Additional paid in capital183,91291,20374,83772,87171,94077,34071,853
Accumulated deficit(148,274)(102,149)(86,938)(66,436)(67,332)(62,383)(41,061)
Other undisclosed stockholders' equity16,01421,38513,662    
Total stockholders' equity:51,68010,4531,5706,4444,61614,96930,802
TOTAL LIABILITIES AND EQUITY:76,64226,61718,50318,38828,84917,09132,408

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues8,208243565753779  
Revenue, net779  
Sublease income145243234
Cost of revenue(4,805)  (771)(320)  
Cost of goods and services sold   (771)(320)  
Gross profit:3,403243565(18)459  
Operating expenses(44,193)(13,490)(14,768)(11,714)(16,626)(21,368)(18,765)
Other undisclosed operating income (loss) (213) 771320  
Operating loss:(40,790)(13,459)(14,202)(10,961)(15,848)(21,368)(18,765)
Nonoperating income (expense)(5,335)(1,752)40511,858(419)  
Investment income, nonoperating  405298112  
Interest and debt expense (308)(995)(1,146)(1,165)  
Loss from continuing operations before equity method investments, income taxes:(46,125)(15,519)(14,792)(249)(17,432)(21,368)(18,765)
Other undisclosed income (loss) from continuing operations before income taxes 308(5,710)1,1461,165  
Income (loss) from continuing operations before income taxes:(46,125)(15,211)(20,502)896(16,267)(21,368)(18,765)
Income tax expense (benefit)(6,413)(4,312)(8,892)(1,692)920  
Net loss:(52,538)(19,522)(29,394)(795)(15,347)(21,368)(18,765)
Other undisclosed net income attributable to parent6,4134,3128,8921,692 4722
Net income (loss) attributable to parent:(46,125)(15,211)(20,502)896(15,347)(21,321)(18,743)
Preferred stock dividends and other adjustments(2,525)(1,737)(13,751)    
Net income (loss) available to common stockholders, diluted:(48,650)(16,948)(34,253)896(15,347)(21,321)(18,743)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(52,538)(19,522)(29,394)(795)(15,347)(21,368)(18,765)
Comprehensive loss, net of tax, attributable to parent:(52,538)(19,522)(29,394)(795)(15,347)(21,368)(18,765)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: